201
This is the first report of a fluoxetine-related death in a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism.
 a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism: Subject; child: Subject.Age; genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism: Subject.Disorder; death: Effect; fluoxetine: Treatment; fluoxetine: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism: Subject; child: Subject.Age; genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism: Subject.Disorder; death: Effect; fluoxetine: Treatment; fluoxetine: Treatment.Drug